Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5897591 | 0.85 | CYP1A2 (0.39) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL1874741 | 0.81 | CYP1A2 (0.39) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL5897765 | 0.78 | CYP1A2 (0.35) | CYP1A2HIF1AALDH1A1 | |
| SCHEMBL31292737 | 0.74 | CHRM2 (0.34) | KDM4EHSD17B10SMN1; SMN2HTTTSHR | |
| SCHEMBL3301366 | 0.73 | CYP1A2 (0.46) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL8020201 | 0.73 | CYP1A2 (0.43) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL9122696 | 0.73 | ALDH1A1 (0.46) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL8020205 | 0.73 | CYP1A2 (0.43) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL29807013 | 0.73 | ALDH1A1 (0.46) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 | |
| SCHEMBL7718731 | 0.73 | CYP1A2 (0.43) | CYP1A2HIF1AKDM4EHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7038087-B2 | Process for the production of optically active amino alcohols | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-05-02 | — | — | US | disclosed |
| US-20040063999-A1 | Process for the production of optically active amino alcohols | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1398310-A1 | Process for the production of optically active amino alcohols | Takasago International Corporation (JP) | 2004-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063999-A1 | Process for the production of optically active amino alcohols | ADH1C, ADH1A, ADH5 | CYP1A2 296/4885HIF1A 2117/4885KDM4E 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.